NVO—FDA briefing docs for Semaglutide panel on 10/18/17: https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm560480.htm